Nifty
:
24471.70
Sensex
:
78154.25
-112.10 (-0.46%)
-388.19 (-0.49%)
Nifty
Sensex
:
:
24471.70
78154.25
-112.10 (-0.46%)
-388.19 (-0.49%)

Strides Pharma Science Ltd.

Pharmaceuticals & Drugs - Global

Rating :
70/99

BSE: 532531 | NSE: STAR

NSE BSE
1002.80
11-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1012.4
  •  1012.4
  •  986
  •  999.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  188504
  •  188178430.6
  •  1231
  •  768.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,246.31
  • 15.07
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 10,701.85
  • 0.50%
  • 2.82

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.91%
  • 3.80%
  • 20.42%
  • FII
  • DII
  • Others
  • 28.4%
  • 13.73%
  • 5.74%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.84
  • 9.61
  • 7.69

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.82
  • 21.40
  • 8.10

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.07
  • 0.38
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.63
  • -
  • 15.66

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.30
  • 2.55
  • 3.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.41
  • 15.46
  • 11.59

Earnings Forecasts:

(Updated: 08-08-2026)
Description
2026
2027
2028
2029
Adj EPS
84
-11
27.14
62.3
P/E Ratio
11.94
-91.16
36.95
16.10
Revenue
16.56
11.19
-
4862.2
EBITDA
5808
7090.6
-
930
Net Income
1114
1469.9
-
574.4
ROA
626.6
928.6
-
-
P/B Ratio
-
-
-
2.96
ROE
2.8
2.28
-
20.1
FCFF
18.3
22.5
-
424.8
FCFF Yield
480.5
656.5
-
3.56
Net Debt
4.03
5.5
-
-
BVPS
-
-
-
339.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
1,265.41
1,119.74
13.01%
1,323.47
1,190.39
11.18%
1,194.65
1,153.67
3.55%
1,220.83
1,166.93
4.62%
Expenses
1,035.63
901.66
14.86%
1,083.76
972.52
11.44%
958.70
943.35
1.63%
989.26
982.33
0.71%
EBITDA
229.77
218.07
5.37%
239.71
217.87
10.02%
235.94
210.31
12.19%
231.57
184.60
25.44%
EBIDTM
18.16%
19.48%
18.11%
18.30%
19.75%
18.23%
18.97%
15.82%
Other Income
4.89
8.58
-43.01%
8.13
11.98
-32.14%
106.86
5.62
1,801.42%
27.14
28.41
-4.47%
Interest
40.56
47.46
-14.54%
41.58
50.32
-17.37%
43.38
52.18
-16.86%
46.13
73.82
-37.51%
Depreciation
56.40
48.89
15.36%
53.25
48.86
8.98%
50.62
48.42
4.54%
49.64
48.45
2.46%
PBT
200.90
121.94
64.75%
146.60
103.25
41.99%
245.51
112.89
117.48%
154.17
86.87
77.47%
Tax
34.12
16.45
107.42%
18.77
20.76
-9.59%
37.35
23.80
56.93%
21.59
13.94
54.88%
PAT
166.78
105.49
58.10%
127.83
82.49
54.96%
208.15
89.09
133.64%
132.57
72.93
81.78%
PATM
13.18%
9.42%
9.66%
6.93%
17.42%
7.72%
10.86%
6.25%
EPS
17.03
10.81
57.54%
13.77
8.92
54.37%
21.93
9.54
129.87%
13.84
7.81
77.21%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
5,004.36
4,858.68
4,565.34
3,890.13
3,688.39
3,070.25
3,315.87
2,751.97
2,178.37
2,845.11
2,755.44
Net Sales Growth
8.07%
6.43%
17.36%
5.47%
20.13%
-7.41%
20.49%
26.33%
-23.43%
3.25%
 
Cost Of Goods Sold
2,009.64
1,958.72
1,979.96
1,749.05
1,626.88
1,502.32
1,332.79
1,122.48
1,085.20
1,378.84
1,281.17
Gross Profit
2,994.72
2,899.95
2,585.37
2,141.07
2,061.50
1,567.93
1,983.08
1,629.49
1,093.18
1,466.28
1,474.27
GP Margin
59.84%
59.69%
56.63%
55.04%
55.89%
51.07%
59.81%
59.21%
50.18%
51.54%
53.50%
Total Expenditure
4,067.35
4,014.13
3,767.56
3,317.89
3,303.09
3,091.76
2,689.06
2,236.07
1,936.06
2,442.83
2,228.09
Power & Fuel Cost
-
66.38
58.17
75.13
85.82
71.54
64.58
64.49
54.39
51.33
33.87
% Of Sales
-
1.37%
1.27%
1.93%
2.33%
2.33%
1.95%
2.34%
2.50%
1.80%
1.23%
Employee Cost
-
928.96
862.76
737.05
732.02
646.91
550.15
442.56
329.44
434.05
419.16
% Of Sales
-
19.12%
18.90%
18.95%
19.85%
21.07%
16.59%
16.08%
15.12%
15.26%
15.21%
Manufacturing Exp.
-
402.64
311.98
299.81
259.45
255.52
237.94
210.79
150.98
141.97
145.40
% Of Sales
-
8.29%
6.83%
7.71%
7.03%
8.32%
7.18%
7.66%
6.93%
4.99%
5.28%
General & Admin Exp.
-
251.45
221.56
198.06
232.21
223.67
191.73
191.89
150.10
194.38
172.63
% Of Sales
-
5.18%
4.85%
5.09%
6.30%
7.29%
5.78%
6.97%
6.89%
6.83%
6.27%
Selling & Distn. Exp.
-
357.11
298.20
215.03
263.65
331.30
223.22
137.07
111.22
208.85
161.12
% Of Sales
-
7.35%
6.53%
5.53%
7.15%
10.79%
6.73%
4.98%
5.11%
7.34%
5.85%
Miscellaneous Exp.
-
48.85
34.93
43.76
103.06
60.51
88.65
66.79
54.74
33.41
161.12
% Of Sales
-
1.01%
0.77%
1.12%
2.79%
1.97%
2.67%
2.43%
2.51%
1.17%
0.53%
EBITDA
936.99
844.55
797.78
572.24
385.30
-21.51
626.81
515.90
242.31
402.28
527.35
EBITDA Margin
18.72%
17.38%
17.47%
14.71%
10.45%
-0.70%
18.90%
18.75%
11.12%
14.14%
19.14%
Other Income
147.02
231.45
63.76
49.85
135.22
133.40
59.44
53.11
40.84
88.32
161.08
Interest
171.65
178.54
248.85
280.22
261.14
176.74
150.06
155.72
79.29
196.24
183.10
Depreciation
209.91
202.40
192.26
213.64
243.25
233.01
206.29
173.70
117.39
154.03
126.15
PBT
747.18
695.06
420.42
128.22
16.11
-297.88
329.90
239.59
86.47
140.32
379.18
Tax
111.83
94.17
77.52
29.11
-55.30
-178.26
31.65
11.32
-26.86
5.68
63.41
Tax Rate
14.97%
14.09%
15.98%
-47.86%
6010.87%
32.91%
8.48%
6.99%
-24.85%
5.87%
18.50%
PAT
635.33
556.19
405.34
-120.20
-221.20
-460.21
254.50
49.16
83.99
54.39
233.51
PAT before Minority Interest
614.41
574.52
409.40
-143.90
-230.90
-474.25
243.79
43.36
89.25
74.26
279.71
Minority Interest
-20.92
-18.33
-4.06
23.70
9.70
14.04
10.71
5.80
-5.26
-19.87
-46.20
PAT Margin
12.70%
11.45%
8.88%
-3.09%
-6.00%
-14.99%
7.68%
1.79%
3.86%
1.91%
8.47%
PAT Growth
81.52%
37.22%
-
-
-
-
417.70%
-41.47%
54.42%
-76.71%
 
EPS
68.91
60.32
43.96
-13.04
-23.99
-49.91
27.60
5.33
9.11
5.90
25.33

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
3,107.57
2,551.83
2,125.57
2,212.26
2,359.23
2,776.66
2,527.42
2,648.70
2,463.66
2,748.82
Share Capital
92.17
92.16
91.90
90.30
89.79
89.68
89.56
89.55
89.50
89.42
Total Reserves
3,014.84
2,459.16
2,030.57
2,102.54
2,266.99
2,682.26
2,432.13
2,551.59
2,365.10
2,650.55
Non-Current Liabilities
598.54
601.61
621.44
1,210.30
965.72
1,264.45
813.65
2,342.88
2,067.29
2,048.67
Secured Loans
536.45
558.62
618.40
1,040.81
744.86
873.43
601.79
1,806.45
1,551.09
1,622.87
Unsecured Loans
15.87
12.62
53.10
98.98
90.77
9.15
2.12
0.06
0.23
14.84
Long Term Provisions
126.36
113.94
91.63
73.42
64.28
246.50
63.95
52.24
16.55
25.19
Current Liabilities
2,895.49
2,591.52
2,879.26
2,990.20
3,411.68
2,738.35
2,544.86
2,662.24
1,896.17
3,103.87
Trade Payables
1,309.68
1,032.50
851.59
982.34
1,071.52
1,134.20
797.75
888.99
712.07
774.09
Other Current Liabilities
401.72
307.41
341.57
527.89
697.18
421.00
354.49
248.12
126.85
819.08
Short Term Borrowings
1,039.34
1,136.36
1,574.15
1,330.76
1,496.53
1,023.84
1,228.78
1,339.02
944.39
1,393.96
Short Term Provisions
144.75
115.25
111.94
149.20
146.43
159.31
163.84
186.11
112.86
116.73
Total Liabilities
6,643.37
5,779.59
5,572.41
6,373.38
6,760.72
6,816.80
5,953.17
7,806.77
6,581.77
8,034.86
Net Block
2,100.35
1,888.12
1,853.18
2,298.42
2,333.45
2,151.13
2,025.85
3,570.13
2,903.00
2,909.03
Gross Block
3,303.39
2,897.25
2,873.18
3,324.82
3,231.69
2,841.28
2,534.38
4,049.05
3,229.03
3,186.12
Accumulated Depreciation
1,203.04
1,009.14
1,020.00
1,026.40
898.24
690.15
508.53
478.92
326.03
277.09
Non Current Assets
3,030.03
2,680.68
2,603.41
3,130.03
3,398.88
3,999.57
3,581.05
4,758.05
4,101.31
4,243.05
Capital Work in Progress
447.28
206.76
161.89
150.98
291.08
447.37
412.95
453.03
620.29
780.18
Non Current Investment
291.36
339.71
196.93
438.96
540.34
598.00
430.44
416.97
276.50
245.06
Long Term Loans & Adv.
163.66
140.19
256.13
217.18
210.58
187.83
214.69
227.76
206.54
222.69
Other Non Current Assets
27.14
94.73
123.38
11.91
10.26
547.00
424.33
12.78
21.40
15.48
Current Assets
3,612.79
3,098.91
2,969.00
3,135.25
3,361.83
2,817.23
2,370.61
3,048.72
2,446.53
3,791.82
Current Investments
0.00
69.50
105.76
50.84
0.00
99.41
118.97
284.75
311.48
1,279.54
Inventories
1,634.79
1,277.57
1,126.24
1,146.51
1,173.80
1,200.70
782.54
874.16
552.02
732.80
Sundry Debtors
1,288.96
1,202.94
1,141.87
1,299.40
1,207.30
1,110.59
931.69
987.18
882.18
995.91
Cash & Bank
213.14
136.78
191.17
315.96
187.35
179.76
237.10
516.65
303.33
329.48
Other Current Assets
475.89
276.20
228.99
169.21
793.39
226.76
300.31
385.98
397.52
454.10
Short Term Loans & Adv.
154.85
135.92
174.97
153.34
145.49
128.54
218.24
249.11
311.71
245.26
Net Current Assets
717.30
507.39
89.74
145.05
-49.84
78.89
-174.25
386.48
550.36
687.95
Total Assets
6,642.82
5,779.59
5,572.41
6,265.28
6,760.71
6,816.80
5,951.66
7,806.77
6,547.84
8,034.87

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
702.52
684.37
701.07
44.41
-257.81
481.44
204.79
60.05
187.07
288.14
PBT
668.69
3,675.03
-62.72
-267.63
-652.51
289.38
48.51
344.37
705.80
497.14
Adjustment
205.39
-2,884.12
818.27
682.19
582.27
363.31
527.49
94.59
-274.51
190.92
Changes in Working Capital
-100.45
-173.58
-78.73
-457.80
-189.90
-328.05
-326.23
-323.14
-190.66
-341.30
Cash after chg. in Working capital
773.63
617.34
676.82
-43.23
-260.14
324.64
249.76
115.82
240.63
346.76
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-71.11
67.04
24.25
87.64
2.33
156.80
-44.98
-55.76
-53.56
-58.62
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-173.04
-89.69
-150.25
302.47
-118.73
-520.82
1,306.16
-148.49
582.59
-686.69
Net Fixed Assets
-175.27
-32.00
-315.30
-54.00
-61.59
-86.75
-167.06
-48.49
677.20
-236.66
Net Investments
-20.59
515.90
128.18
-92.01
-5.11
-224.10
-21.67
-372.21
743.57
-147.22
Others
22.82
-573.59
36.87
448.48
-52.03
-209.97
1,494.89
272.21
-838.18
-302.81
Cash from Financing Activity
-453.41
-642.58
-693.32
-213.92
421.32
-15.80
-1,709.45
194.27
-1,015.69
338.21
Net Cash Inflow / Outflow
76.07
-47.90
-142.51
132.96
44.77
-55.18
-198.50
105.83
-246.03
-60.33
Opening Cash & Equivalents
112.56
161.02
303.50
170.73
125.83
182.23
365.89
256.16
515.08
1,110.74
Closing Cash & Equivalent
188.70
112.56
161.02
303.50
170.73
125.83
182.23
365.89
256.16
515.08

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
337.08
276.83
230.95
242.83
262.48
309.09
281.55
294.94
274.26
306.41
ROA
9.25%
7.21%
-2.41%
-3.52%
-6.99%
5.35%
2.00%
5.22%
9.59%
5.79%
ROE
20.31%
17.52%
-6.67%
-10.15%
-18.49%
12.91%
5.34%
14.74%
27.00%
16.53%
ROCE
18.57%
16.56%
3.47%
-0.49%
-9.49%
11.17%
6.01%
8.65%
16.07%
10.75%
Fixed Asset Turnover
2.28
2.46
1.96
1.91
1.75
2.04
1.50
1.17
1.04
1.27
Receivable days
64.34
60.35
73.17
73.25
79.41
68.09
70.88
79.95
102.49
96.77
Inventory Days
75.20
61.86
68.12
67.80
81.35
66.13
61.20
61.00
70.11
64.20
Payable days
218.23
173.66
191.36
230.40
267.95
264.54
138.58
146.59
116.23
117.33
Cash Conversion Cycle
-78.69
-51.45
-50.07
-89.35
-107.20
-130.32
-6.50
-5.64
56.37
43.64
Total Debt/Equity
0.54
0.70
1.14
1.27
1.18
0.76
0.78
1.22
1.03
1.35
Interest Cover
4.75
2.96
0.59
-0.10
-2.69
3.49
2.00
5.92
4.68
3.71

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Strides Pharma Scien - Quarterly Results
    1st Aug 2026, 00:00 AM

    Read More
  • Strides Pharma’s Bangalore facility receives five observations from USFDA
    21st May 2026, 14:11 PM

    The USFDA had conducted a routine current cGMP inspection at the facility during the period from May 12, 2026 to May 20, 2026

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.